Yakın Zamanda İntakraniyal Hadisesi Olan Hastada Akut Koroner Sendroma Yaklaşım
Özet
İntrakraniyal hadise (özellikle intrakraniyal hemoraji [İKH] veya iskemik inme) öyküsü olan hastalarda akut koroner sendrom (AKS) yönetimi, yüksek mortalite ve komplikasyon riski nedeniyle önemli klinik zorluklar taşır. İskemi sonrası rekanalizasyon, antitrombosit veya antikoagülan tedavilerin beyin kanamasını tetikleme potansiyeli, multidisipliner yaklaşım gerektiren karmaşık karar süreçlerini beraberinde getirir. Bu bölümde, söz konusu hasta grubunda AKS yönetimine ilişkin patofizyolojik mekanizmalar, acil değerlendirme ve risk skorlama yöntemleri, revaskülarizasyon seçenekleri, antitrombosit ve antikoagülasyon stratejileri, tedavi zamanlamasına yönelik öneriler ile klinik uygulamaya ışık tutacak pratik bir algoritma sunulmaktadır.
Referanslar
Byrne RA, Rossello X, Coughlan JJ, et al. 2023 ESC Guidelines for the management of acute coronary syndromes. Eur Heart J. 2023;44(38):3720-3826.
Greenberg SM, Ziai WC, Cordonnier C, et al. 2022 Guideline for the Management of Patients With Spontaneous Intracerebral Hemorrhage: A Guideline From the American Heart Association/American Stroke Association. Stroke.2022;53(7):e282-e361.
RESTART Collaboration. Effects of antiplatelet therapy after stroke due to intracerebral haemorrhage (RESTART): a randomised, open-label trial. Lancet. 2019;393(10191):2613-2623. doi:10.1016/S0140-6736(19)30840-2
Ha ACT, Bhatt DL, Rutka JT, Johnston SC, Mazer CD, Verma S. Intracranial Hemorrhage During Dual Antiplatelet Therapy: JACC Review Topic of the Week. J Am Coll Cardiol. 2021;78(13):1372-1384.
Zhao X, Ai G, Qiu M, et al. Efficacy of clopidogrel and ticagrelor under NT-proBNP in hospitalized ST-elevation acute coronary syndrome patients on percutaneous coronary intervention: CCC-ACS Project Analysis. Int J Cardiol. 2020;310:1-8.
Georgiopoulos G, Kraler S, Mueller-Hennessen M, et al. Modification of the GRACE Risk Score for Risk Prediction in Patients With Acute Coronary Syndromes. JAMA Cardiol. 2023;8(10):946-956.
Stone GW, Witzenbichler B, Guagliumi G, et al. Bivalirudin during primary PCI in acute myocardial infarction. N Engl J Med. 2008;358(21):2218-2230.
Valgimigli M, Frigoli E, Leonardi S, et al. Bivalirudin or Unfractionated Heparin in Acute Coronary Syndromes. N Engl J Med. 2015;373(11):997-1009.
Valgimigli M, Frigoli E, Heg D, et al. Dual Antiplatelet Therapy after PCI in Patients at High Bleeding Risk. N Engl J Med. 2021;385(18):1643-1655.
Urban P, Meredith IT, Abizaid A, et al. Polymer-free Drug-Coated Coronary Stents in Patients at High Bleeding Risk. N Engl J Med. 2015;373(21):2038-2047.
Windecker S, Latib A, Kedhi E, et al. Polymer-based or Polymer-free Stents in Patients at High Bleeding Risk. N Engl J Med. 2020;382(13):1208-1218.
Wiviott SD, Braunwald E, McCabe CH, et al. Prasugrel versus clopidogrel in patients with acute coronary syndromes. N Engl J Med. 2007;357(20):2001-2015.
Bhatt DL, Stone GW, Mahaffey KW, et al. Effect of platelet inhibition with cangrelor during PCI on ischemic events. N Engl J Med. 2013;368(14):1303-1313. doi:10.1056/NEJMoa1300815
Dershowitz L, Lawlor MK, Hamid N, et al. Right ventricular remodeling and clinical outcomes following transcatheter tricuspid valve intervention. Catheter CardiovascInterv.2024;103(2):367-375
Mehran R, Baber U, Sharma SK, et al. Ticagrelor with or without Aspirin in High-Risk Patients after PCI. N Engl J Med. 2019;381(21):2032-2042.
